Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

New orally active thrombin inhibitors from Merck & Co.

Nov. 3, 1997

Ortho discloses peptide serine protease inhibitors

Oct. 30, 1997

Advisory committee recommends approval for Plavix

Oct. 29, 1997

New serine protease inhibitors for thrombotic disorders from Akzo Nobel

Oct. 29, 1997

Factor Xa inhibitors from Zeneca for use as anticoagulants/antithrombotics

Oct. 27, 1997

Patents issued to Corvas for serine protease inhibitors

Oct. 22, 1997

Gensia receives FDA approval for desmopressin acetate injection

Oct. 21, 1997

Two large trials support use of alteplase accelerated infusion for acute MI

Oct. 20, 1997

Staphylokinase vs. alteplase for thrombolysis in rabbit stroke model

Oct. 16, 1997

Hirudin more effective than heparin in heart attack patients

Oct. 15, 1997

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
SERCA inhibitor from Sumitomo shows promise for MSA-C treatment
BioWorld Science
At the ongoing International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2026) in Copenhagen, Sumitomo Pharma Co....